Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants

INTRODUCTION: The DAPA-CKD trial assessed dapagliflozin in patients with chronic kidney disease (CKD) with or without type 2 diabetes (T2D). To aid interpretation of results, renal and cardiovascular outcomes plus healthcare resource utilization (HCRU) and costs were assessed in a real-world populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Olufade, Tope, Lamerato, Lois, Sánchez, Juan José García, Jiang, Like, Huang, Joanna, Nolan, Stephen, Rangaswami, Janani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889671/
https://www.ncbi.nlm.nih.gov/pubmed/33474707
http://dx.doi.org/10.1007/s12325-020-01609-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889671/
https://www.ncbi.nlm.nih.gov/pubmed/33474707
http://dx.doi.org/10.1007/s12325-020-01609-2

Ejemplares similares